Literature DB >> 32078202

How to ask about the use of new psychoactive substances to increase the validity of results in self-report prevalence surveys.

Eva Drapalova1, Vendula Belackova1, Agnès Cadet-Taïrou2.   

Abstract

INTRODUCTION AND AIMS: New psychoactive substances (NPS) represent hundreds of novel compounds. However, the general public might not be familiar with the overarching term NPS. This can result in both under- and over-reporting of NPS use. DESIGN AND METHODS: The study analysed the last-year prevalence of NPS use in an online survey conducted across I-TREND project countries (the Czech Republic, the Netherlands and Poland). Self-reported NPS use was assessed within two types of questions-a generic and a checklist question. We analysed prevalence for each question separately, incorporated the free-text probe 'other' that followed them, and combined the two questions into a conservative and an inclusive estimate.
RESULTS: Including free-text responses to the 'other' categories increased prevalence of NPS use (from 51% to 56% for the checklist question and 25% to 32% for the generic question). Taking an inclusive approach to estimating prevalence (i.e. indicating NPS use in either a generic list or from the checklist) yielded a higher prevalence estimate (60%, 95% confidence interval 58-62%), compared to a more conservative approach in which NPS use had to be affirmed by both questions (27%, 95% confidence interval 26-29%). DISCUSSION AND
CONCLUSIONS: Generic questions might lead to notably lower estimates of self-reported NPS use in comparison to checklists. However, creating relevant checklists is challenging and lengthy survey instruments have limitations. Further surveys might benefit from featuring a combination of the strategies used in this study-a single (generic) question involving a number of locally specific NPSs and a free-text 'other' probe.
© 2020 Australasian Professional Society on Alcohol and other Drugs.

Keywords:  NPS checklist; new psychoactive substances; online survey; self-reported prevalence; validity

Mesh:

Substances:

Year:  2020        PMID: 32078202     DOI: 10.1111/dar.13036

Source DB:  PubMed          Journal:  Drug Alcohol Rev        ISSN: 0959-5236


  1 in total

1.  Prevalence of Novel Psychoactive Substance (NPS) Use in Patients Admitted to Drug Detoxification Treatment.

Authors:  Michael Specka; Thomas Kuhlmann; Jürgen Sawazki; Udo Bonnet; Renate Steinert; Monika Cybulska-Rycicki; Helmut Eich; Benita Zeiske; Antje Niedersteberg; Luzia Schaaf; Norbert Scherbaum
Journal:  Front Psychiatry       Date:  2020-07-07       Impact factor: 4.157

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.